医学
结肠镜检查
结直肠癌筛查
结直肠癌
入射(几何)
内科学
肿瘤科
胃肠病学
癌症
物理
光学
作者
Reinier Meester,Iris Lansdorp–Vogelaar,Sidney J. Winawer,Timothy R. Church,John I. Allen,Andrew D. Feld,Glenn Mills,Paul Jordan,Douglas A. Corley,Chyke A. Doubeni,Anne I. Hahn,Stephanie Lobaugh,Martin Fleisher,Michael J. O’Brien,Ann G. Zauber
标识
DOI:10.14309/ajg.0000000000002693
摘要
INTRODUCTION: Modeling supporting recommendations for colonoscopy and stool-based colorectal cancer (CRC) screening tests assumes 100% sequential participant adherence. The impact of observed adherence on the long-term effectiveness of screening is unknown. We evaluated the effectiveness of a program of screening-colonoscopy every ten years versus annual high-sensitivity guaiac-based fecal occult blood testing (HSgFOBT) using observed sequential adherence data. METHODS: MIcrosimulation SCreening ANalysis (MISCAN) model using observed sequential screening adherence, HSgFOBT positivity, and diagnostic-colonoscopy adherence in HSgFOBT-positive individuals from the National Colonoscopy Study (NCS; single screening-colonoscopy versus ≥4 HSgFOBT sequential rounds). We compared CRC incidence and mortality over 15 years with no screening, or ten-yearly screening-colonoscopy versus annual HSgFOBT with 100% and differential observed adherence from the trial. RESULTS: Without screening, simulated incidence and mortality over 15 years were 20.9 (95% probability interval, 15.8-26.9) and 6.9 (5.0-9.2) per 1000 participants, respectively. In the case of 100% adherence, only screening-colonoscopy was predicted to result in lower incidence; however, both tests lowered simulated mortality to a similar level (2.1 [1.6-2.9] for screening-colonoscopy; 2.5 [1.8-3.4] for HSgFOBT). Observed adherence for screening-colonoscopy (83.6%) was higher than observed sequential HSgFOBT adherence (73.1% first round; 49.1% by round 4), resulting in lower simulated incidence and mortality for screening-colonoscopy (14.4 [10.8-18.5] and 2.9 [2.1-3.9], respectively) than HSgFOBT (20.8 [15.8-28.1] and 3.9 [2.9-5.4], respectively), despite a 91% adherence to diagnostic-colonoscopy with FOBT positivity. The relative risk of CRC mortality for screening-colonoscopy versus HSgFOBT was 0.75 (95%PI, 0.68-0.80). Findings were similar in sensitivity analyses with alternative assumptions for repeat colonoscopy, test performance, risk, age, and projection horizon. DISCUSSION: Where sequential adherence to stool-based screening is suboptimal and colonoscopy is accessible and acceptable – as observed in NCS – offering screening-colonoscopy can increase screening effectiveness.
科研通智能强力驱动
Strongly Powered by AbleSci AI